期刊文献+

2型糖尿病合并败血症81例临床分析 被引量:3

Clinical analysis of 81 cases of type 2 Diabetes mellitus with septicemia
下载PDF
导出
摘要 目的:探讨2型糖尿病并发败血症患者的临床特点,以提高诊治水平。方法:败血症合并糖尿病组81例,无合并糖尿病组78例,比较两组间的病原菌特点,感染途径,预后和转归,治疗时间和费用。结果:与无糖尿病组比较,合并2型糖尿病的败血症患者革兰阴性菌感染例数、病情重者例数较多,感染性休克的发生率更高,住院时间更长,住院费用更多,未愈和病死率更高(均为P<0.05)。结论:合并糖尿病的败血症患者以革兰阴性菌感染为主,病情重,应及早选用针对性强的抗生素治疗及行对症治疗。 Objective : To explore the clinical features of septicemia in patients with Type 2 Diabetes mellitus Methods: 81 cases of septicemic patients with type 2 Diabetic and 78 patients without diabetes were retrospectively analyzed. The pathogens, primary infection site, prognosis, duration of therapy, and treatment costs were ana- lysed. Results: Compared with non-diabetic patients, patients with DM had higher rate of Gram-negative bactere- mia, mortality, incidence of septic shock and treatment costs, longer time for therapy. Conclusion: The main pathogen in septicemia patients with type 2 diabetes mellitus were Gram-negative bactia, with serious symptoms. Early diagnosis and promptly sufficient antibiotic treatment is very important in those patients.
出处 《新医学》 2013年第4期253-255,共3页 Journal of New Medicine
关键词 糖尿病 2型 败血症 革兰阴性菌 Diabetes mellitus, type 2 Septicemia Gram-negative bacteremia
  • 相关文献

参考文献10

二级参考文献25

共引文献83

同被引文献61

  • 1涂新明,木内吉宽.无菌ICR小鼠和普通ICR小鼠血‘液中生化正常值的测定和比较[J].中国实验动物学杂志,1996,6(2):91-93. 被引量:21
  • 2王芳,房建伟,王泽宇,斗章.高脂血症大鼠肠道菌群变化的实验研究[J].黑龙江医药科学,2005,28(4):52-53. 被引量:31
  • 3郭健飞,付广文,张光珍,白洁,陈丽.CRP及颈动脉超声检测对2型糖尿病的临床意义及相关分析[J].山东医药,2006,46(7):40-41. 被引量:4
  • 4Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage[J]. Proc Natl Acad Sci U S A, 2004, 101(44): 15718-15723.
  • 5Neal MD~ Leaphart C, Levy R, et al. Enterocyte TLR4 medi- ates phagocytosis and translocation of bacteria across the intesti- nalbarrier[J].J Immunol, 2006, 176(5):3070-3079.
  • 6Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbi- ota in human adults with type 2 diabetes differs from non-diabet- ic aduhs[J]. PLoS One, 2010, 5(23 : e9085.
  • 7Le KA, Li Y, Xu X, et al. Alterations in fecal Lactobacillus and Bifidobaeterium species in type 2 diabetic patients in South- ern China population. Front Physiol, 2012. 3: p. 496.
  • 8Angelopoulos N, Goula A, Tolis G. Current knowledge in the neurophysiologic modulation of obesity[J].Metabolism, 2005, 54(9) : 1202-1217.
  • 9Watts T, Berti I, Sapone A, et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats~[J]. Proe Natl Acad Sci U S A, 2005, 102(8) :2916-2921.
  • 10Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced di- abetes in mice through a mechanism associated with endotoxae- mia[J].Diabetologia, 2007, 50(11), 2374-2383.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部